Mechanisms of increased bioavailability through amorphous solid dispersions: a review
Amorphous solid dispersions (ASDs) can increase the oral bioavailability of poorly soluble drugs. However, their use in drug development is comparably rare due to a lack of basic understanding of mechanisms governing drug liberation and absorption in vivo. Furthermore, the lack of a unified nomencla...
Saved in:
Main Authors: | Andreas Schittny (Author), Jörg Huwyler (Author), Maxim Puchkov (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Particle Forming Amorphous Solid Dispersions: A Mechanistic Randomized Pharmacokinetic Study in Humans
by: Andreas Schittny, et al.
Published: (2021) -
Explaining the Release Mechanism of Ritonavir/PVPVA Amorphous Solid Dispersions
by: Adrian Krummnow, et al.
Published: (2022) -
Spray-Dried Amorphous Solid Dispersions of Atorvastatin Calcium for Improved Supersaturation and Oral Bioavailability
by: Jaewook Kwon, et al.
Published: (2019) -
Hot-Melt Extruded Amorphous Solid Dispersion for Solubility, Stability, and Bioavailability Enhancement of Telmisartan
by: Bhupendra Raj Giri, et al.
Published: (2021) -
Applications of Dynamic Mechanical Analysis in the Engineering of Amorphous Solid Dispersions
by: Andrew Toye Ojo, et al.
Published: (2020)